Rite Aid (RAD) Front-End Comps Rose 0.9% in June
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Nasdaq climbs to record after softer jobs data cools rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Twilio, Vylor set to join S&P 500 as index reshuffles members
- Wells Fargo names 13 stocks as overweight tactical ideas
Goldman Sachs Comments on Rite-Aid (RAD) June Sales Data
July 3, 2014 10:38 AM EDTGoldman Sachs maintained a Buy rating on Rite-Aid (NYSE: RAD) with a price target of $9.50. Comments follow June sales data. Analyst Robert P. Jones noted this was the strongest script comp since January 2013.
"RADs June SSS increased 3.9%, exceeding GS/consensus of 3.4%/2.8%, with script... More
Rite Aid (RAD), Walgreen (WAG) Gain on Strong June Sales Results
July 3, 2014 9:22 AM EDTRetail pharmacy giants Walgreen (NYSE: WAG) and Rite Aid (NYSE: RAD) are positive Thursday following June sales results.
Walgreen reported... More
